Is Numinus Wellness Inc. (NUMIF) a Buy, Sell, or Hold?
Numinus Wellness Inc.
OTC:NUMIF
$0.03433 USD
$0.0 (-1.35%)
- Volume
- 12.4K
- Average Volume
- 166.46K
- Market Capitalization
- $11M
- P/E Ratio
- -1.49
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.06
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.61
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Michael Tan |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Current Symbol | NUMIF |
| CUSIP | 67054W103 |
| CIK | None |
| Web | https://www.numinus.com |
| Phone | 833 686 4687 |
| Currency | USD |
| Employees | 200 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | -1.49 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.61 |
| Quick Ratio | 0.61 |
| Cash Ratio | 0.20 |
Sales & Book Value
| Annual Sales | $4.17M |
| Price / Sales | 4.83 |
| Cash Flow | -0.01 |
| Price / Cash Flow | -4.96 |
| Price / Book | -9.44 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.0495 |
| Trailing P/E Ratio | -1.49 |
| PEG Ratio | -0.03 |
| P/E Growth | -0.03 |
| Net Income | $-19.64M |
| Net Margin | -297.88% |
| Pretax Margin | -303.15% |
| Return on Equity | 833.04% |
| Return on Assets | -230.35% |
Financials Score
| AltmanZ Score | -53.83 |
| Piotroski Score | 2.00 |
| Working Capital | -1.59M |
| Total Assets | 4.29M |
| Ebit | -10.44M |
| Market Cap | 12.18M |
| Total Liabilities | 5.84M |
Poll Results
About Numinus Wellness Inc. (OTC:NUMIF) Stock
Numinus Wellness Inc. is dedicated to pioneering and delivering psychedelic-assisted psychotherapy, with the overarching goal of reshaping the mental healthcare landscape. The company's operations are segmented into two primary divisions: Salvation Botanicals and Numinus Health. Salvation Botanicals provides comprehensive laboratory services focused on psychedelics, encompassing cultivation, analytical testing, product research and development, and various ancillary supports. Additionally, this division offers both full-suite and bespoke testing for cannabis products. Numinus Health concentrates on promoting healing, connection, and personal growth through a range of supportive therapies and advanced technologies. This division specializes in addressing mental health challenges and substan ... ce abuse, delivering services including psychotherapy, counselling, neurofeedback, physiotherapy, and other therapeutic modalities. Furthermore, Numinus Health equips practitioners with vital training, facilities, and operational resources. The company's headquarters are situated in Vancouver, Canada.
Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies
2026-04-20 08:30:00
Company's clinical research operations and therapist training programs directly positioned to support accelerated research and commercialization timelines Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Numinus Wellness Inc. (OTC: NUMIF) today acknowledged the Executive Order signed by President Donald J. Trump directing United States federal agencies to accelerate research, access, and regulatory review for psychedelic-based treatments, including psilocybin, ibogaine, MDMA, and LSD.
Frequently Asked Questions
-
What is the current Numinus Wellness Inc. (NUMIF) stock price?
-
Numinus Wellness Inc.(OTC:NUMIF) stock price is $0.03433 in the last trading session. During the trading session, NUMIF stock reached the peak price of $0.056 while $0.006 was the lowest point it dropped to. The percentage change in NUMIF stock occurred in the recent session was --1.35% while the dollar amount for the price change in NUMIF stock was -$-0.0.
-
NUMIF's industry and sector of operation?
-
The OTC listed NUMIF is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
-
Who are the executives of NUMIF?
-
Reid J. Robison | Chief Clinical Officer
Paul Thielking | Chief Science & Medical Officer
Ian Noble | Chief Communications Officer
Jason Lapensee | Senior Vice President of Clinic Operations
Kelvin Yang | Chief Financial Officer -
How many employees does NUMIF have?
-
Number of NUMIF employees currently stands at 200. NUMIF operates from 33 Water Street, Vancouver, BC V6B 1R4, CA.
-
Link for NUMIF official website?
-
Official Website of NUMIF is: https://www.numinus.com
-
How do I contact NUMIF?
-
NUMIF could be contacted at phone #833 686 4687 and can also be accessed through its website. NUMIF operates from 33 Water Street, Vancouver, BC V6B 1R4, CA.
-
How many shares of NUMIF are traded daily?
-
The average number of NUMIF shares traded daily for last 3 months was 166.46K.
-
What is the market cap of NUMIF currently?
-
The market value of NUMIF currently stands at $11M with its latest stock price at $0.03433